Abbott Financial Statements From 2010 to 2025

ABL Stock  EUR 108.92  1.30  1.18%   
Abbott Laboratories financial statements provide useful quarterly and yearly information to potential Abbott Laboratories investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Abbott Laboratories financial statements helps investors assess Abbott Laboratories' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Abbott Laboratories' valuation are summarized below:
Abbott Laboratories does not presently have any fundamental signals for analysis.
Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott Laboratories' main balance sheet or income statement drivers, such as , as well as many indicators such as . Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules.
  
This module can also supplement various Abbott Laboratories Technical models . Check out the analysis of Abbott Laboratories Correlation against competitors.
For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Abbott Laboratories Company EBITDA Analysis

Abbott Laboratories' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Abbott Laboratories EBITDA

    
  12.13 B  
Most of Abbott Laboratories' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abbott Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

According to the company disclosure, Abbott Laboratories reported earnings before interest,tax, depreciation and amortization of 12.13 B. This is much higher than that of the Other sector and significantly higher than that of the Other industry. The ebitda for all Germany stocks is notably lower than that of the firm.

Abbott Laboratories Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Abbott Laboratories's current stock value. Our valuation model uses many indicators to compare Abbott Laboratories value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abbott Laboratories competition to find correlations between indicators driving Abbott Laboratories's intrinsic value. More Info.
Abbott Laboratories is the top company in current valuation category among its peers. It also is number one stock in price to book category among its peers . The ratio of Current Valuation to Price To Book for Abbott Laboratories is about  35,283,034,960 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Abbott Laboratories' earnings, one of the primary drivers of an investment's value.

About Abbott Laboratories Financial Statements

Abbott Laboratories shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Abbott Laboratories investors may analyze each financial statement separately, they are all interrelated. The changes in Abbott Laboratories' assets and liabilities, for example, are also reflected in the revenues and expenses on on Abbott Laboratories' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Abbott Stock Analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.